Please use a PC Browser to access Register-Tadawul
Get It
Stock Ratings | Potential Upside of 506%! JMP Securities has given an initial rating on MBX Biosciences (MBX) with a target price of $38
TRAVERE THERAPEUTICS INC -1.15%
Benitec Biopharma Limited Sponsored ADR -1.97%
Spire Global, Inc. Class A Common Stock +2.16%
MBX Biosciences +0.19%
Nurix Therapeutics -1.85%
TRAVERE THERAPEUTICS INC TVTX | 20.70 | -1.15% |
Benitec Biopharma Limited Sponsored ADR BNTC | 12.92 | -1.97% |
Spire Global, Inc. Class A Common Stock SPIR | 10.18 | +2.16% |
MBX Biosciences MBX | 10.29 | +0.19% |
Nurix Therapeutics NRIX | 9.55 | -1.85% |
Major US investment bank ratings are used to track the latest valuations and target prices on Wall Street daily, and to explore potential stock investment opportunities.
Today's Key Ratings and Concerns
Canaccord Genuity: Maintained a "Buy" rating on TRAVERE THERAPEUTICS INC(TVTX.US) , raising the price target from $45 to $47.
JMP Securities: Maintained an “Outperform” rating for Benitec Biopharma Limited Sponsored ADR(BNTC.US) , raising the price target from $18 to $20.
Canaccord Genuity: Maintained a "Buy" rating on Spire Global, Inc. Class A Common Stock(SPIR.US) , raising the price target from $14.5 to $15.5.
JMP Securities: Initial rating for MBX Biosciences(MBX.US) is "Outperform", with a target price of $38.
Wells Fargo: Maintained an “overweight” rating on Nurix Therapeutics(NRIX.US) , lowered the price target from $32 to $25.
| The symbol | Classification | Target price | Current price | Potential increase/decrease rate | (Classification) Agency |
| TRAVERE THERAPEUTICS INC(TVTX.US) | to lift | $47.0 | $13.49 | 248.41% | Canaccord Genuity |
| Benitec Biopharma Limited Sponsored ADR(BNTC.US) | to lift | $20.0 | $11.94 | 67.5% | JMP Securities |
| Spire Global, Inc. Class A Common Stock(SPIR.US) | to lift | $15.5 | $9.69 | 59.96% | Canaccord Genuity |
| Western Digital Corporation(WDC.US) | to lift | $55.0 | $34.87 | 57.73% | Benchmark |
| Sensata Technologies Holding NV(ST.US) | to lift | $27.0 | $19.44 | 38.89% | Goldman Sachs |
| MBX Biosciences(MBX.US) | Initial classification | $38.0 | $6.27 | 506.06% | JMP Securities |
| Nurix Therapeutics(NRIX.US) | cut | $25.0 | $8.81 | 183.77% | Wells Fargo |
| Tempest Therapeutics, Inc. - Common Stock(TPST.US) | cut | $16.0 | $5.86 | 173.04% | HC Wainwright & Co. |
| Ivanhoe Electric Inc.(IE.US) | cut | $13.0 | $5.0 | 160.0% | JP Morgan |
| Ivanhoe Electric Inc.(IE.US) | cut | $13.0 | $5.0 | 160.0% | JP Morgan |
Notes: Target price and current price unit: US Dollar; Current price: as of the latest closing price of US stocks; Potential Upside/Downside Ratio = (Agency Target Price - Current Price) / Current Price 100% (Current Price = Last Close Price up to the time of census)
Lifting
Morgan Stanley: Upgraded AppLovin Corporation(APP.US) to "Overweight", lowered the price target from $470 to $350.
Goldman Sachs: Upgraded Aurora Innovation, Inc. - Class A Common Stock(AUR.US) to "Neutral", with a price target increase from $3 to $6.
Wells Fargo: Maintained a “market-weight” rating on Axis Capital Holdings Limited(AXS.US) , raising the price target from $97 to $100.
UBS: Maintains a “Buy” rating on Axis Capital Holdings Limited(AXS.US) , raising the price target from $105 to $115.
JMP Securities: Maintained an “Outperform” rating for Benitec Biopharma Limited Sponsored ADR(BNTC.US) , raising the price target from $18 to $20.
First coverage
Canaccord Genuity: Initial rating for BlackSky Technology Inc. Class A Common Stock(BKSY.US) with a "Buy" recommendation and a $12 price target.
TD Cowen: Initial rating for Casella Waste Systems, Inc. Class A(CWST.US) with a "Buy" recommendation and a $130 price target.
Mizuho: Initial rating for Dectron Internationale Inc. Ordinary Shares(DEC.US) at "Outperform", with a target price of $23.
Mizuho: Initial rating of "Outperform" on DexCom, Inc.(DXCM.US) , with a target price of $85.
Mizuho: Initial rating for Embrace Systems Corp.(EMBC.US) with a "Neutral" rating and a $15 price target.
Reduction
Barclays: Maintained a “market-weight” rating on Agilent Technologies, Inc. (A.US) , while lowering the price target from $138 to $115.
JP Morgan: Maintains a "Neutral" rating on Alcoa Inc.(AA.US) , lowers the price target from $40 to $28.
TD Cowen: Maintained a "Hold" rating on AllianceBernstein Holding L.P.(AB.US) , lowered the price target from $37.5 to $34.
UBS: Maintains 'Buy' rating on Arch Capital Group Ltd.(ACGL.US) , lowers price target from $127 to $124.
UBS: Maintains a "Neutral" rating on Adient plc(ADNT.US) , lowers the price target from $20 to $13.
